Skip to search.
 FTSE 100 Down 0.58%

More On BTGGF

Quotes

Derivatives

  • Warrants
  • Investment Products

Charts

News & Info

Company

Analyst Coverage

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials

  • Income Statement
  • Balance Sheet
  • Cash Flow

BTG plc (BTGGF)

-Other OTC Ticker: 100159/ISIN: GB0001001592
10.62 Down 0.58(5.18%) 27 Mar 18:18
Add to Portfolio
Prev Close:11.20
Open:N/A
Bid:N/A
Ask:N/A
1y Target Est:N/A
Beta:N/A
Next Earnings Date:N/A
Day's Range:N/A - N/A
52wk Range:8.20 - 12.55
Volume:0
Avg Vol (3m):1,144
Market Cap:4.05b
P/E (ttm):65.96
EPS (ttm):0.16
Div & Yield:N/A (N/A)
Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.

Key Statistics

Forward P/E (1 yr):0.65
P/S (ttm):8.30
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Mar-14) :14.14
Quarterly EPS Est (0-00-31) :N/A
Mean Recommendation*:N/A
PEG Ratio (5 yr expected):1.11

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

BTG plc, a specialist healthcare company, develops and commercializes products targeting critical care, cancer, and varicose veins. It operates through three segments: Specialty Pharmaceuticals, Interventional Medicine, and Licensing & Biotech... more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback